A potentially more effective treatment for HER2 mutant metastatic breast cancer
A phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read MoreA phase II clinical trial is on its way to assess the value of poziotinib in the treatment of this devastating condition.
Read MoreThe event was an opportunity to highlight basic research achievements of the department trainees and staff.
Read MoreResearchers identified a molecule in the blood that is produced during exercise and can effectively reduce food intake and obesity in mice.
Read MoreThe new findings help us understand how longevity is regulated at a whole organism level.
Read MoreThe findings are an example of how viruses can evolve by incorporating structurally distinct modules with similar functionality.
Read MoreDEC-Tec can accelerate the development of potentially more effective anti-cancer drugs with reduced side effects.
Read MoreA selection of From the Labs Images of the Month is on display on the A Hallway at Main Baylor. Come and visit!
Read MoreDr. Zoghbi is being recognized for two discoveries – ATAXIN1, the gene responsible for spinocerebellar ataxia 1, and MECP2, the gene responsible for Rett syndrome.
Read MoreResearch Spotlight highlights contributions of Baylor faculty to their field of interest.
Read MoreThe findings support a diagnostic algorithm to identify the cancer subtype and guide specialized treatment.
Read More